Cholangiocarcinoma
📧 Sign up to get email alerts when something new happens for Cholangiocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone [NA]
A completed clinical trial comparing minimally invasive versus open pancreaticoduodenectomy for pancreaticobiliary cancers.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment [Phase 2]
Phase 2 clinical trial evaluating lenvatinib plus paclitaxel in patients with advanced biliary tract cancer after gemcitabine-based therapy;…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Preoperative Right Hepatic Artery Embolization for Locally Advanced Bismuth IIIb and IV Perihilar Cholangiocarcinoma [NA]
This clinical trial update covers preoperative right hepatic artery embolization for locally advanced, non-resectable Bismuth IIIb/IV perihi…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal Tract
This clinical trial update describes the collection of tissue and blood from patients with benign and malignant tumors of the soft tissue an…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Pemigatinib + Afatinib in Advanced Refractory Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating the combination of pemigatinib and afatinib in advanced, unresectable, or metastatic solid tumors is cur…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Hepatobiliary and Pancreatic Tumor Biobank
Clinical trial update describing a hepatobiliary and pancreatic tumor biobank study led by Zhejiang University, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating pemigatinib plus atezolizumab and bevacizumab for advanced cholangiocarcinoma with FGFR2 fusion, current…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Imfinzi BTC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Durvalumab (Imfinzi) is studied in a Japan post-marketing surveillance PMS for biliary tract cancer; the study has completed.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Exploration of Sintilimab + Bevacizumab + AG Chemotherapy as First-Line Treatment for Unresectable Advanced/Metastatic Cholangiocarcinoma [Phase 2]
This is a Phase 2 clinical trial exploring a combination of sintilimab, bevacizumab, and AG chemotherapy as first-line treatment for unresec…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Ivosidenib Plus Durvalumab and Gemcitabine/Cisplatin as First-Line Therapy in Participants With Locally Advanced or Metastatic Cholangiocarcinoma With an IDH1 Mutation [Phase 1, Phase 2]
This clinical trial evaluates the combination of ivosidenib, durvalumab, and gemcitabine/cisplatin as first-line therapy for locally advance…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Efficacy and Safety of TT-00420 (Tinengotinib) Tablets Versus Chemotherapy in Patients With Advanced Intrahepatic Cholangiocarcinoma Harboring FGFR2 Fusions/Rearrangements or Mutations [Phase 3]
A Phase 3 trial evaluating Tinengotinib (TT-00420) versus chemotherapy in patients with advanced intrahepatic cholangiocarcinoma harboring F…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors [Phase 1]
Phase 1 study of Felmetatug Vedotin (SGN-B7H4V) in advanced solid tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Liver and Biliary Tumor Tissue Registry
Mayo Clinic's Liver and Biliary Tumor Tissue Registry (NCT02917759) has been terminated.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis [NA]
A clinical trial comparing supra-papillary versus trans-papillary biliary stenting in malignant peri-hilar obstruction is not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: New Prospective Expanded German Registry of Incidental Gallbladder Carcinoma (PERSUASION)- a Permanent Platform Including All Kind of Biliary Tract Cancers (BTC)
The PERSUASION registry, a prospective German platform for biliary tract cancers including gallbladder carcinoma, has completed its expanded…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]
APL-5125 is being studied in a Phase 1/2 trial for adults with advanced solid tumors, with recruitment ongoing across several indications in…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Analysis of the Incidence of Cholangiocarcinoma on Choledochal Cyst in a Western Center
A clinical trial update shows a study led by María Teresa Moreno Asencio investigating the incidence of cholangiocarcinoma in patients with …
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Target-specific immunoPET Imaging of Digestive System Carcinoma [NA]
A recruiting clinical trial evaluating a target-specific immunoPET imaging agent for digestive system carcinomas across multiple digestive c…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement [Phase 2]
Phase 2 study evaluating Futibatinib in patients with advanced cholangiocarcinoma harboring FGFR2 fusions; trial status is recruiting.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Observational Study Protocol: LIVER-R
An observational study protocol called LIVER-R sponsored by AstraZeneca focusing on hepatobiliary cancers, currently recruiting.
-
CLINICAL_TRIALS other · 2025-12-26Clinical Trial Update: Effect of 37℃ Non-ionic Contrast Agent During ERCP Procedure in Hilar Cholangiocarcinoma [NA]
This ClinicalTrials.gov entry evaluates a 37°C non-ionic contrast agent used during ERCP in patients with cholangitis and hilar cholangiocar…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Clinical Application of PET Imaging Targeting CLDN18.2 in Malignant Tumors
A clinical trial is evaluating PET imaging targeting CLDN18.2 for detecting malignant tumors, with recruitment ongoing in gastric cancer, pa…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA) [Phase 4]
Phase 4 clinical trial evaluating a perioperative bundle including hydrocortisone, octreotide, and a teres ligament patch to reduce postoper…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Adjuvant Chemotherapy for BTC Based on 3D-PTA [Phase 2]
Phase 2 trial evaluating adjuvant chemotherapy for biliary tract cancer (cholangiocarcinoma) based on 3D-PTA; currently not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: NXP800 for the Treatment of Patients With Advanced or Metastatic Cholangiocarcinoma [Phase 1]
Phase 1 trial of NXP800 for advanced or metastatic cholangiocarcinoma has been terminated.